Playlist Mode Print Mode Enable Media Only

News chronological

10 items before 1152104 (Keyword: "clinical-study" (~35 currently found))

NEWSNATIONNOW (Josie Fischels) - GLP-1-driven vitamin deficiency linked to rare brain disorder: Study

Researchers found a rare but potentially life-threatening brain disorder in a small number of people taking Ozempic, Wegovy and similar drugs.

NEWSNATIONNOW (Stephanie Sokol) - GLP-1 prescriptions for kids up more than 30,000% since 2019

Kids with obesity-related conditions like high cholesterol or sleep apnea were substantially more likely to be prescribed GLP-1s than those without.

NEWSNATIONNOW (NewsNation Staff) - GLP-1 weight-loss drugs show promise for sleep apnea

Obstructive sleep apnea affects nearly one billion adults worldwide and is linked to serious health problems.

YOUTUBE (Facts Matter with Roman Balmakov) - Fillers and BBLs Using Fat From the Dead

Watch Final Hours https://ept.ms/WatchFullFinalHours Up to $20,000 of Free Silver: https://ept.ms/3biH9MN How badly do you want that perfect beach body? Some are willing to get liposuction and have someone shuffle their own fat around. But how about getting one’s body enhanced by injecting fat from dead people? Is that a bit much? Well, that’s what’s happening in the cosmetics industry. Now, you might ask: Why do they need to use fat from cadavers? Why not just liposuction one area, and move it to another? Here’s the twist: the rise of GLP-1 weight loss drugs are leaving people without enough fat to move around. Let’s go through it all together. #botox #cosmeticsurgery #fat #factsmatter © All Rights Reserved.

NEWSNATIONNOW (Rob Taub) - Psilocybin may help prevent painful chemotherapy side effect, study finds

A new study suggests psilocybin could protect nerves from chemotherapy damage, potentially helping patients avoid a debilitating side effect.

NYTIMES (Gina Kolata) - The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

NEWSNATIONNOW (Alicia Sitz) - GLP-1s may work by activating an unlikely weight loss ally

A neuron known for stimulating hunger is actually triggered into overdrive by semaglutide.

NYTIMES (Carolyn Y. Johnson) - An Experimental Single-Time Treatment Slashed Cholesterol for a Year

A small gene-editing study significantly reduced LDL cholesterol levels, and the results have stuck a year later.

NEWSNATIONNOW (Josie Fischels) - New weight loss drug may burn fat without muscle loss seen in GLP-1 drugs

A new experimental compound helped mice burn more energy without eating less, raising hopes for a different approach to weight loss.